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Abstract 1 
Periodontal inflammation can inhibit cell differentiation of periodontal ligament cells 2 
(PDLCs), resulting in decreased bone/cementum-regeneration ability. The Wnt signalling 3 
pathway, including canonical Wnt/β-catenin signalling and non-canonical Wnt/Ca
2+
 4 
signalling, plays essential roles in cell proliferation and differentiation during tooth 5 
development. However, it is still little known whether non-canonical Wnt/Ca
2+
 signalling 6 
cascade could regulate cementogenic/osteogenic differentiation capability of PDLCs within 7 
inflammatory environment. Therefore, in this study, hPDLCs and their cementogenic 8 
differentiation potential was investigated in the presence of cytokines. The data demonstrated 9 
that both cytokines interleukin-6 (IL-6) and tumor necrosis factor alpha (TNFα) inhibited cell 10 
proliferation, relative alkaline phosphatase (ALP) activity, bone/cementum-related 11 
gene/protein expression, and canonical Wnt pathway related gene/protein expression in 12 
hPDLCs.  Interestingly, both cytokines up-regulated the non-canonical Wnt/Ca
2+
 signalling 13 
related gene and protein expression in hPDLCs. When Wnt/Ca
2+
 pathway was blocked by 14 
Ca
2+
/calmodulin-dependent protein kinase II (CAMKII) inhibitor KN93, even in the presence 15 
of IL-6 and TNFα, cementogenesis could be stimulated in hPDLCs. Our data indicate that 16 
Wnt/Ca
2+
 pathway plays an inhibitory role on PDLCs cementogenic differentiation in 17 
inflammatory microenvironments. Therefore, targeting Wnt/Ca
2+
 pathway may provide a 18 
novel therapeutic approach to improve periodontal regeneration for periodontal diseases. 19 
 20 
Keywords: Cytokines, Wnt/Ca
2+
 pathway, periodontal ligament cells, cementogenic 21 
differentiation  22 
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Introduction 1 
Periodontitis is a chronic oral inflammatory disease caused by accumulation of bacteria that 2 
lead to inflammation of periodontium (Loe and others 1965).  The host response to 3 
periodontal pathogens would result in the breakdown of connective tissues and resorption of 4 
alveolar bone (Graves 2008; Kornman and others 1997). Periodontal ligament cells (PDLCs) 5 
are the dominant cells in periodontal tissues and respond to bacteria to produce several pro-6 
inflammatory cytokines, such as interleukin (IL)-1β, IL-6, IL-8 and tumor necrosis factor 7 
alpha (TNFα) at the site of inflammation, thereby leading to destruction of periodontal 8 
ligament, cementum and alveolar bone (Kornman and others 1997; Okada and Murakami 9 
1998; Yamaji and others 1995). Among these cytokines, increasing evidences demonstrated 10 
that both IL-6 and TNFα have been reported to have a strong potential for increasing bone 11 
resorption and to be involved in the degradation of connective tissues (Azuma and others 12 
2013; Graves and Cochran 2003; Stashenko and others 1987).  13 
PDLCs have the capacity to differentiate into osteoblastic, fibroblastic and cementoblastic 14 
lineages (Han and others 2012; Liu and others 2009; Seo and others 2004; Silverio and others 15 
2010) in vitro and showed the potential to form cementum-like tissue in vivo (Seo and others 16 
2004). It is known that cell-signalling cascades regulate the differentiation of PDLCs (Han 17 
and others 2012; Zhou and others 2012). And the Wnt signalling pathway, including 18 
canonical Wnt/β-catenin signalling and non-canonical Wnt/Ca
2+
 signalling, has been proven 19 
to play essential roles in cell proliferation and differentiation during tooth development 20 
(Katoh and Katoh 2007). Recent findings demonstrated that canonical Wnt signalling could 21 
stimulate cell proliferation and osteogenic differentiation in PDLCs (Han and others 2012; 22 
Heo and others 2010), and Wnt5a could regulate growth, patterning and odontoblast 23 
differentiation during odontogenesis, at least partially by modulating canonical Wnt 24 
signalling (Lin and others 2011). However, it is unknown whether Wnt/Ca
2+
 signalling is 25 
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capable of modulating cementogenic/osteogenic differentiation of PDLCs, especially under 1 
inflammatory microenvironments.  2 
The primary aim of this study was to investigate the regulation of pro-inflammatory 3 
cytokines IL-6 and TNFα in in vitro cementogenic/osteogenic differentiation of PDLCs and 4 
unveil the role of Wnt/Ca
2+
 signalling underlying this process.  5 
Materials and methods 6 
Isolation and culture of hPDLCs  7 
Human periodontal ligament cells (hPDLCs) were isolated and cultured according to our 8 
previous publication (Han and others 2012). The Human Ethics Committee of Queensland 9 
University of Technology, following informed consent taken from all the participants, 10 
approved the use of hPDLCs in this study. Briefly, third molars were obtained from three 11 
healthy patients (18-25 years old) who underwent third molar extraction surgery. Periodontal 12 
ligament tissues were separated from the middle third of the root surface using a scalpel and 13 
were cultured in a T25 flask in Dulbecco’s Modified Eagle Medium (DMEM; Gibco-14 
Invitrogen, Australia) supplemented with 10% v/v fetal bovine serum (FBS; Thermo 15 
Scientific, Australia) and 50 U/mL penicillin and 50 mg/mL streptomycin (P/S; Gibco-16 
Invitrogen, Australia) at 37
o
C in a humidified CO2 incubator. The medium was changed 17 
every three days and the outgrown cells growing around the PDL tissues were passaged at 18 
approximately 80% confluence. Cells at passages P2-P5 were used for in vitro assays in this 19 
study.  20 
Cell morphology, proliferation and differentiation in the presence of IL-6 and TNFα 21 
The osteogenic differentiation medium contained DMEM supplemented with 10% FBS, 100 22 
nM dexamethasone, 50 mg/ml of ascorbic acid, and 10mM β-glycerophosphate (Sigma, St 23 
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Louis, MO, USA). To investigate the effect of pro-inflammatory cytokines (IL-6 and TNFα) 1 
on the morphology, proliferation and differentiation of hPDLCs, proliferation assay, relative 2 
ALP activity and mineralization assay were conducted. hPDLCs were stimulated with IL-6 at 3 
10 and 50 ng/mL and TNFα at 10 and 50 ng/mL (R&D Systems, Australia) respectively, in 4 
the osteogenic medium. The cells culturing in osteogenic medium alone were used as the 5 
control group in this study. 6 
To determine the cell morphology with skeleton and nuclei, hPDLCs were cultured in 7 
osteogenic differentiation media under inflammatory environment. After 3 days culture, cells 8 
were fixed with 4% paraformaldehyde (PFA, Sigma-Aldrich, Australia) solution for 30 mins 9 
at room temperature and then was and permeabilized with 0.2% Triton X-100/PBS solution 10 
for 5 mins after washed by PBS once. Samples were then incubated for 1 hr with 0.5% 11 
BSA/PBS containing 0.8 U/ml fluorescein isothiocyanate (FITC, Sigma-Aldrich, Australia) 12 
and 5µg/ml DAPI (Sigma-Aldrich, Australia). The cells were visualized with ElispeTis 13 
fluorescent microscope (Nikon Instruments Inc., Australia).  14 
For the cell proliferation, 3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide 15 
(MTT, Sigma-Aldrich, Australia) assay was performed in triplicate according to our previous 16 
study protocol (Han and others 2012; Wu and others 2011a; Wu and others 2011b). 0.5 17 
mg/mL of MTT solution was added to each well of 96-well culture plate and incubated in 18 
37
o
C for 4 h to form the formazan crystals. Then the media were replaced by using 100 µL of 19 
dimethyl sulfoxide (DMSO, Sigma-Aldrich, Australia) to dissolve the formazan. The 20 
absorbance of formazan-DMSO solution was measured at λ=495 nm by SpectraMax 21 
Microplate Reader (Molecular Devices, Inc., USA).  22 
The relative ALP activity was assessed at day 7 and 14 after hPDLCs culturing with a 23 
seeding density of 1x10
4
 per blank culture plate well (Han and others 2012; Wu and others 24 
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2011a; Wu and others 2011b). Briefly, the cells were washed with PBS three times to remove 1 
the media, and then lysed in 200 µL of 0.2% Triton
®
 X-100 (Sigma-Aldrich, Australia). 2 
Lysates were centrifuged at 14,000 rpm for 5 min at 4
o
C and 50 µL of supernatants mixed 3 
with 150 µL ALP assay working solution according to the manufacturer’s protocol 4 
(QuantiChrom
TM
 Alkaline Phosphatase Assay Kit, BioAssay Systems, USA). The total 5 
protein content was measured by the bicinchoninic acid protein assay kit (Thermo Scientific, 6 
Australia). The optical density (OD) was measured at 405 nm on a plate reader. The relative 7 
ALP activity was obtained as the changed OD values divided by the reaction time and total 8 
protein content. 9 
The calcium concentration of hPDLCs was measured at day 7 and 14 culturing in the 10 
presence of pro-inflammatory cytokines. The cells were washed with ddH2O three times to 11 
remove the medium, and then lysed in 100 µL of 0.6N HCl. The lysates were centrifuged at 12 
14,000 rpm for 15 min at 4
o
C and 5 µL of  supernatant mixed with 200 µL of the assay 13 
working solution according to the manufacturer’s protocol (QuantiChrom
TM
 Calcium Assay 14 
Kit, BioAssay Systems, USA). 15 
Cementogenic/osteogenic-related gene expression of hPDLCs stimulated by IL-6 and 16 
TNFα  17 
The effect of IL-6 and TNFα on hPDLCs cementogenic/osteogenic differentiation was 18 
assessed by real-time quantitative PCR (RT-qPCR) to measure the mRNA expression of 19 
alkaline phosphatase (ALP), osteopontin (OPN), cementum protein 1 (CEMP1) and 20 
cementum attachment protein (CAP) in all treatment groups. Cells were harvested at day 3 21 
and 7 after the treatment and then total RNA was isolated using Trizol Reagent
®
 (Invitrogen) 22 
according to the manufacturer’s instructions. Complementary DNA was synthesized using 23 
DyNAmo
TM
 cDNA Sythesis Kit (Finnzymes, Genesearch, Australia) following the 24 
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manufacturer’s instructions. The primers used in this study were listed in Table 1. RT-qPCR 1 
was performed on an ABI Prism 7300 Thermal Cycler (Applied Biosystems, Australia) with 2 
SYBR Green detection reagent. The relative mRNA expressions of ALP, OPN, OCN, 3 
CEMP1 and CAP were assayed and normalized against the housekeeping gene 4 
glyceraldehyde-3-phosphate-dehydrogenase (GAPDH). Each sample was performed in 5 
triplicate. The mean cycle threshold (Ct) value of each target gene was normalized against Ct 6 
value of GAPDH and the relative expression calculated using the following formula: 2
-
7 
(normalized average Cts) 
×10
4
. 8 
Wnt canonical and non-canonical signalling related gene expression of hPDLCs  9 
To investigate the effect of IL-6 and TNFα on Wnt signalling related the gene expression for 10 
hPDLCs, canonical Wnt-related genes of Wingless-3a (WNT3a), low-density lipoprotein 11 
receptor-related protein 5 (LRP5), axis inhibition protein 2 (AXIN2), beta-cadherin-12 
associated protein (CTNNB), Dickkopf-related protein 1 (DKK1) and non-canonical Wnt 13 
related genes of Wingless-5a (WNT5A), Frizzled-6 (FZD6) were analysed by RT-qPCR as the 14 
same method in section 2.4. 15 
Protein extraction and Western Blotting for differentiation markers and Wnt pathway in 16 
hPDLCs  17 
Western Blotting analysis was performed for the detection of the protein expression. In brief, 18 
whole cell lysates were obtained from the cells culturing for 7 days under the cytokines; 19 
nuclear protein was extracted using Nuclear Extraction Kit according to manufacturer’s 20 
instruction (Abcam, Australia) and the protein concentration was determined by the BCA 21 
Protein Assay Kit (Thermo Fisher Scientific, Australia). 10 µg proteins from each sample 22 
were separated on 10% sodium dodecyl sulfate polyacrylamide (SDS-PAGE) gel 23 
electrophoresis and then transferred into a nitrocellulose membrane (Pall Corporation, East 24 
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Hills, NY, USA). After blocking for 1 h with Odyssey® blocking buffer (Millennium Science, 1 
Australia), the membranes were incubated with the primary antibodies against ALP (1:1000, 2 
rabbit anti-human; Abcam, USA), OCN (1:2000, rabbit anti-human; Abcam, USA), CAP 3 
(1:1000, mouse anti-human; Santa Cruz Biotechnology, Inc., USA), β-catenin (1:1000, rabbit 4 
anti-human; Cell Signaling Technology, Inc., USA), Axin2 (1:2000 rabbit anti-human; 5 
Abcam, USA), Ca
2+
/calmodulin-dependent protein kinases II (CaMKII, 1:1000, rabbit anti-6 
human; Cell Signaling Technology, Inc., USA), Phospho-CaMKII (1:1000, rabbit anti-human; 7 
Cell Signaling Technology, Inc., USA), and GAPDH (1:1000, mouse anti-human; Abcam, 8 
USA) overnight at 4
o
C. Then all the membranes were incubated with corresponding 9 
fluorescent secondary antibodies (1:4000, Cell Signaling Technology, Inc., USA). Targeted 10 
proteins were visualized using the Odyssey® infrared imaging system (LI-COR 11 
Biotechnology Inc., USA). In additio , the relative intensity of protein bands was quantified 12 
using ImageJ software in triplicate. 13 
The effect of Wnt/Ca
2+
inhibitor KN93 in cementogenic differentiation for hPDLCs 14 
To further investigate the effect of Wnt/Ca
2+
 signalling in relation to cementogenic/ 15 
osteogenic differentiation of hPDLCs, one of the effective CAMKII inhibitors KN93 (Castle 16 
Hill, NSW, Australia), was added at the concentration of 10 µM directly in the osteogenic 17 
culture medium containing specific concentration of IL-6 and TNFα. After 1 and 3 days, the 18 
effect of KN93 on cementogenic and Want-related gene/protein expression for hPDLCs was 19 
carried out as described in Sections 2.4 and 2.5.  20 
Statistical analysis 21 
All the measurements were presented as means ± standard deviation (SD) and were analysed 22 
using Student’s T-test. Analysis was performed using SPSS software (SPSS Inc., Chicago, Il, 23 
USA). A value of p<0.05 was considered to be statistically significant. 24 
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Results 1 
The effect of IL-6 and TNFα on morphology, proliferation of hPDLCs  2 
The evaluation of hPDLCs morphology was performed after 3 days of culture with different 3 
concentrations of IL-6 and TNFα (Fig. 1). The cells were spread well in blank culture plates 4 
after culturing for 3 days in the presence of both cytokines IL-6 and TNFα (Fig. 1). The MTT 5 
assay showed that the proliferation of hPDLCs increased obviously in a time dependent 6 
manner in each group. It is noted that overall cell proliferation rate was comparable between 7 
both IL-6 and TNFα cytokines treatment groups and control group. However, the 8 
proliferation of hPDLCs was significantly decreased by IL-6 and TNFα treatment at the 9 
concentration of 50ng/mL when compared to control group at day 1, 3 and 7 (Fig. 2a).  10 
The relative ALP activity of hPDLCs was comparable between cytokines treatments and 11 
control groups at day 7 (Fig. 2b). Whi e ALP activity of hPDLCs showed a significant 12 
decrease with 50 ng/mL of IL-6 and TNFα compared to other groups (p<0.05) at day 14 (Fig. 13 
2b). There was no significance difference for the calcium deposition across different groups 14 
at day 7. However, 50 ng/mL of IL-6 and TNFα significantly reduced the calcium deposition 15 
for hPDLCs at day 14 (Fig. 2c). 16 
The expression of bone and cementum-related genes of hPDLCs  17 
RT-qPCR analysis showed that pro-inflammation cytokines reduced the osteogenic/ 18 
cementogenic differentiation of hPDLCs with various degrees. Bone-related genes expression 19 
of ALP and OPN for hPDLCs was significantly down-regulated by IL-6 and TNFα at the 20 
concentration of 50 ng/mL, compared to those of other groups at both day 3 and 7 (Fig. 3a, b). 21 
It is noted that overall decreased trend was observed with respect to CEMP1 and CAP gene 22 
expression for hPDLCs treated with IL-6 and TNFα at the concentration of 50ng/mL, 23 
compared to that of control group (Fig. 3c, d).  24 
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Regulation of IL-6 and TNFα on canonical Wnt-related genes for hPDLCs  1 
The analysis of the expression of canonical Wnt-related genes such as WNT3a, LRP5, AXIN2 2 
CTNNB and DKK1 was performed by RT-PCR after culturing hPDLCs with both IL-6 and 3 
TNFα and blank group for 3 and 7 days (Fig. 4). The results showed that the expression of 4 
WNT3A, LRP5, AXIN2 and CTNNB of hPDLCs with cytokines treatment was significantly 5 
lower than control group at both day 3 and 7 (Fig. 4a-d). However, both IL-6 and TNFα at the 6 
concentration of 50ng/mL significantly increased the expression of DKK1 for hPDLCs than 7 
that of control group at both day 3 and 7 (Fig. 4e).  8 
Non-canonical Wnt related gene expression of for hPDLCs with IL-6 and TNFα  9 
The non-canonical Wnt-related gene expression was further investigated by RT-PCR for 10 
hPDLCs cultured with IL-6 and TNFα and blank group (Fig. 5). At both day 3 and 7, the 11 
expression of non-canonical Wnt genes WNT5A and FZD6 was higher for hPDLCs with both 12 
cytokines treatments than that of control group (Fig. 5a-c).  13 
Bone/cementum and Wnt-related protein expression for hPDLCs in the presence of 14 
cytokines  15 
To investigate the effect of IL-6 and TNFα on protein expression levels for hPDLCs, cells 16 
were cultured with IL-6 and TNFα for 7 days, at concentrations of 10 and 50 ng/mL 17 
respectively (Fig. 6). Osteogenesis related protein ALP was significantly decreased with 18 
cytokines treatment compared to control group; while there was no CAP expression when 19 
treated with cytokines. Canonical Wnt-related AXIN2 and CTNNB protein expression was 20 
significantly down-regulated for hPDLCs with cytokine treatments, compared to the control 21 
group. Results of canonical Wnt-related protein expression analysis of both CAMKII and p-22 
CAMKII protein expression was significantly enhanced for hPDLCs by IL-6 and TNFα.  23 
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The effect of KN93 on cementum and Wnt-related gene/protein expression for hPDLCs  1 
The effect of KN93 (Wnt/Ca
2+
 inhibitor) at the concentration of 10µM on hPDLCs cementum 2 
and WNT-related gene/protein expression was evaluated when culturing with cytokines IL-6 3 
and TNFα at the concentration of 50ng/mL (Fig 7). Gene expression of CEMP1 and CAP for 4 
hPDLCs was up-regulated by KN93 itself when compared to the cells with osteogenic 5 
differentiation media only (Fig.7 a, b). Moreover, cementum-related genes CEMP1 and CAP 6 
were also increased in the presence of KN93 when hPDLCs cultured with cytokines IL-6 and 7 
TNFα compared to that of non-KN93 treatments. The fold change of Wnt/Ca
2+
 related genes 8 
of WNT5A was also significantly inhibited by the WNT inhibitor of KN93 (Fig. 7c).  9 
Interestingly, it was noted that when culturing KN93 at the concentration of 10µM for 3 days, 10 
protein expression level of CAP of hPDLCs was higher than that without WNT inhibitor 11 
(Fig.7d). The effect of KN93 on Wnt/Ca
2+
 related protein for hPDLCs was evaluated after 12 
culturing with/without cytokines for 3 days. It is apparent that KN93 supressed the protein 13 
expression for CAMKII for hPDLCs compared to that from non-KN93 treatment group. 14 
Moreover, the nuclear CTNNNB was enhanced by KN93 even with the cytokines when 15 
compared to cytokines-only control group. However, p-CAMKII and CTNNB showed no 16 
significant difference with KN93 treatment for hPDLCs compared to control group. 17 
Discussion 18 
In this study, we have explored the effect of pro-inflammation cytokines IL-6 and TNFα on 19 
the proliferation, osteogenic/cementogenic differentiation, mineralization as well as the 20 
gene/protein expression of bone, and Wnt-related pathways of hPDLCs. Our recent study 21 
observed that these cytokines supressed hPDLCs cementogenic/osteogenic differentiation, 22 
and canonical Wnt-related gene protein expression; however significantly promoted 23 
Wnt/Ca
2+ 
signalling for hPDLCs. Furthermore, the study further identified that Wnt/Ca
2+
 24 
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inhibitor KN93 could significantly stimulate cementogenic/osteogenic differentiation of 1 
hPDLCs. This indicates that Wnt/Ca
2+
 signalling may be a negative regulator for 2 
cementogenic/osteogenic related gene/protein expression of hPDLCs in inflammatory 3 
microenvironment.  4 
Increasing evidence showed that pro-inflammatory cytokines, such as TNFα and IL-6, are 5 
key mediators, which inhibited the osteogenesis of periodontal ligament fibroblasts in 6 
inflammatory microenvironments during periodontitis progression (Graves 2008). Therefore, 7 
we used TNFα and IL-6 stimulation to mimic the inflammatory microenvironments and 8 
investigated the effect of TNFα and IL-6 on osteogenesis/cementogenesis in hPDLCs. It is 9 
noted that pro-inflammatory environments have preponderance of cytokines, like TNFα and 10 
IL-6, are known to create osteo-inhibitory conditions (Wahl and others 2010). The osteo-11 
inhibitory effect of pro-inflammatory cytokines was confirmed by observing relatively lower 12 
gene/protein expression of bone-related markers ALP and OPN for hPDLCs. ALP is known 13 
as an early marker for osteoblastic differentiation; OPN is another important gene related to 14 
the bone mineralization (Alford and Hankenson 2006; Chen and others 1993; Ivaska and 15 
others 2004). However, no studies yet investigate whether these cytokines have an effect on 16 
cementogenic differentiation of hPDLCs. It is known that CEMP1 and CAP are the 17 
cementum-related markers which have been identified to express in cementum or cementum-18 
like tissues (Alvarez-Perez and others 2006; Arzate and others 1992; Wu and others 1996). In 19 
this study, cementogenic-related markers of CEMP1 and CAP were found to be down-20 
regulated by pro-inflammatory cytokines TNFα and IL-6. These primary data demonstrated 21 
that pro-inflammation cytokines had played as negative modulators during hPDLCs ostegenic 22 
and cementogenic differentiation process. 23 
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Simultaneously, the effect of pro-inflammation cytokines TNFα and IL-6, on canonical Wnt 1 
signalling pathways of hPDLCs was further investigated in an effort to find possible 2 
underlying molecular mechanisms for pro-inflammation cytokines to suppress cementogenic/ 3 
osteogenic differentiation of hPDLCs. The Wnt signalling pathway plays a major role in 4 
various processes during development including cell proliferation and differentiation (Logan 5 
and Nusse 2004). The stabilization of interaction between Wnt1 class ligands (Wnt1, Wnt3, 6 
Wnt3A, Wnt7A, Wnt7B, Wnt8A) and Frizzled-LRP5/6 co-receptors is known to be involved 7 
in intracellular canonical WNT signal transduction, which results in the inhibition of GSK-3β 8 
and the accumulation of cytoplasmic β-catenin (Schweizer and Varmus 2003). WNT3a is a 9 
secreted glycoprotein that interacts with cell membrane-associated proteins and plays an 10 
important role in various development process (Derfoul and others 2004). LRP5 is a 11 
transmembrane low-density lipoprotein receptor that binds and internalizes Wnt ligands in 12 
the process of receptor-mediated endocytosis. In addition, recent studies reported that gain-13 
of-function mutations in LRP5 caused high bone mass (Little and others 2002). Axin2, also 14 
known as conductin, or Axil, is recognised as the most accurate reporter gene in the Wnt 15 
canonical pathway since it is a direct target gene of Wnt ligand binding and activation of the 16 
Wnt signalling pathway (Yu and others 2005). Our results showed that pro-inflammatory 17 
cytokines significantly decreased the canonical Wnt-related genes expression (WNT3A, LRP5, 18 
AXIN2 and CTNNB) and protein expression (AXIN2 and CTNNB) in hPDLCs. Whereas, 19 
gene expression of DKK1 was seen to be up-regulated by inflammatory environment. DKK1 20 
gene encodes a protein that is involved in embryonic development through it  inhibition of 21 
the canonical Wnt signalling pathway (Fedi and others 1999). These data suggest that both 22 
TNFα and IL-6 may be involved in inactivation of canonical Wnt signalling pathway for 23 
reducing the osteogenic/cementogenic differentiation. 24 
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Whereas, canonical Wnt pathway has been considered as inhibitors of non-canonical 1 
pathways as they act through β-catenin independent pathways, including Wnt/Ca
2+
 pathway 2 
and the non-canonical planar cell polarity (PCP) pathway (Maye and others 2004). WNT-3 
Ca
2+
 signalling is a poorly characterised  non-canonical WNT signalling and triggered in 4 
response to activation of Wnt5a-FZD6/2 complexes with stimulation of Ca-calmodulin-5 
dependent protein kinase II (CaMKII) to trigger the release of calcium ions from intracellular 6 
storage, leading to control cell fate and migration (Caverzasio 2009; Cheng and others 2008). 7 
Our results showed that pro-inflammatory cytokines TNFα and IL-6 significantly enhanced 8 
gene expression of key molecules for the Wnt/Ca
2+
 signalling pathway, such as WNT5A, 9 
FZD2 and FZD6, compared to control groups. Furthermore, it is noted that protein expression 10 
level of hPDLCs was elevated with both p-CAMKII and CAMKII by inflammatory cytokines. 11 
On the other hand, KN-93 has been proven as a selective CAMK II inhibitor, which has been 12 
implicated in the regulation of smooth muscle contractility (Tessier and others 1999). In this 13 
study, we further investigated the cementum-related genes and Wnt-related genes expression 14 
in the presence of Wnt/Ca
2+
 pathway inhibitor KN93 for hPDLCs. It was interesting to see 15 
that Wnt/Ca
2+
 inhibitor did increase cementum-related gene/protein expression CEMP1 and 16 
CAP of hPDLCs even in the presence of inflammatory cytokines in hPDLCs. Therefore, it is 17 
speculated that cytokines IL-6 and TNFα supressed cementogenic differentiation of hPDLCs 18 
by activating Wnt/Ca
2+
 pathway. In other words, Wnt/Ca
2+
 pathway might be a negative 19 
regulator during periodontal disease progression; while targeting Wnt/Ca
2+
 pathway may 20 
provide a new concept for periodontal treatment. However, this concept needs to be tested 21 
with over-expression (or knockdown) genetic experiments and in vivo to further demonstrate 22 
that functional cementum-like tissues can be initiated by targeting Wnt/Ca
2+
 pathway. 23 
Conclusions 24 
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In summary, both cytokines IL-6 and TNFα were found to act as an inhibitory regulator on 1 
PDLCs cementogenic differentiation via activation of Wnt/Ca
2+ 
pathway and blocking 2 
canonical Wnt pathway could induce cementogenic differentiation in hPDLCs under 3 
inflammatory cytokines, indicating that targeting Wnt/Ca
2+ 
pathway may provide a novel 4 
therapeutic approach for periodontal diseases. 5 
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Figure legend 1 
Figure 1. The cell morphology of hPDLCs cultured with osteogenic medium in the presence 2 
of different concentrations of IL-6 and TNFα for 3 days.  3 
Figure 2. The cell proliferation (a), relative ALP activity (b) and calcium concentration (c) of 4 
hPDLCs cultured with osteogenic medium in the presence of different concentrations of IL-6 5 
and TNFα.  Osteo (O): osteogenic medium. *: significant difference (p<0.05) between IL-6 6 
treatment group and control group **: significant difference (p<0.05) between TNFα 7 
treatment group and control group 8 
Figure 3. The relative gene expression of bone-related genes of ALP, OPN and cementum-9 
related genes of CEMP1, CAP for hPDLCs cultured with osteogenic medium in the presence 10 
of different concentrations of IL-6 and TNFα. *: significant difference (p<0.05) between IL-6 11 
treatment group and control group **: significant difference (p<0.05) between TNFα 12 
treatment group and control group 13 
Figure 4. The relative gene expression of Wnt canonical-related genes of WNT3A, LRP5, 14 
CTNNB, AXIN2 and DKK1 for hPDLCs cultured with osteogenic medium in the presence of 15 
different concentration of IL-6 and TNFα. *: significant difference (p<0.05) between IL-6 16 
treatment group and control group **: significant difference (p<0.05) between TNFα 17 
treatment group and control group 18 
Figure 5. The relative gene expression of non-canonical Wnt related genes of WNT5A and 19 
FZD6 for hPDLCs cultured with osteogenic medium in the presence of different 20 
concentrations of IL-6 and TNFα. *: significant difference (p<0.05) between IL-6 treatment 21 
group and control group **: significant difference (p<0.05) between TNFα treatment group 22 
and control group 23 
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Figure 6. The Western blotting assay (d) and relative intensity analysis (a-c) for hPDLCs 1 
cultured with osteogenic medium in the presence of different concentrations of IL-6 and 2 
TNFα for 7 days. The relative intensity analysis of Western Blotting protein bands showed 3 
that hPDLCs has no CAP and CTNNB expression with cytokines treatment compared to 4 
control group. While, both cytokines decreased protein expression of ALP and AXIN2 5 
compared to that of control group. Moreover, protein expression of CAMKII and p-CAMKII 6 
significantly increased by both cytokines. 7 
Figure 7. The effect of Wnt/Ca2+ pathway inhibitor KN93 (at the concentration of 10µM) 8 
for hPDLCs cultured with osteogenic medium with IL-6 and TNFα at the concentration of 9 
50ng/mL. (a, b) The cementum-related gene CEMP1 and CAP expression of hPDLCs after 10 
culturing with KN93 for 1, 3 days. (c) Gene expression of WNT5A was investigated for 11 
hPDLCs with KN93. (d) Western Blotting analysis for hPDLCs when culturing with KN93 12 
for 3 days. 13 
 14 
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Table 1 Primer pairs used in qRT-PCR analysis 
Gene Forward primer Reverse primer 
ALP 5' TCAGAAGCTAACACCAACG 3' 5' TTGTACGTCTTGGAGAGGGC 3' 
OPN 5' TCACCTGTGCCATACCAGTTAA 3' 5' TGAGATGGGTCAGGGTTTAGC 3' 
CEMP1 5' GGGCACATCAAGCACTGACAG 3' 5' CCCTTAGGAAGTGGCTGTCCAG 3' 
CAP 5' CTGCGCGCTGCACATGG 3' 5' GCGATGTCGTAGAAGGTGAGCC 3' 
WNT3A 5' TGGACAAAGCTACCAGGGAGT 3' 5' CCCACCAAACTCGATGTCCTC 3' 
LRP5 5' CCGTCATTGGCATCATCCTC 3' 5' GTCCATGTTGTACAGGGAGG 3' 
AXIN2 5' CCCCAAAGCAGCGGTGC 3' 5' GCGTGGACACCTGCCAG 3' 
CTNNB 5' GCTACTGTTGGATTGATTCGAAATC 3' 5' CCCTGCTCACGCAAAGGT 3' 
DKK1 5' TCCGAGGAGAAATTGAGGAA 3' 5' CACAGTCTGATGACCGGAGA 3' 
WNT5A 5' TCTCAGCCCAAGCAACAAGG 3' 5' GCCAGCATCACATCACAACAC 3' 
FZD6 5' GCGGAGTGAAGGAAGGATTAG 3' 5' ACAAGCAGAGATGTGGAACC 3' 
GAPDH 5' TCAGCAATGCCTCCTGCAC 3' 5' TCTGGGTGGCAGTGATGGC 3' 
18s 5’ TTCGGAACTGAGGCCATGAT 3' 5’ CGAACCTCCGACTTCGTTC 3' 
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